Department of Pharmaceutical Sciences, University of Navarra, Irunlarrea 1, E-31008 Pamplona, Spain.
Department of Pharmacology, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
Int J Mol Sci. 2024 Jul 16;25(14):7799. doi: 10.3390/ijms25147799.
There is an urgent need to develop safer and more effective modalities for the treatment of numerous pathologies due to the increasing rates of drug resistance, undesired side effects, poor clinical outcomes, etc. Over the past decades, cyclodextrins (CDs) have gathered great attention as potential drug carriers due to their ability to enhance their bioactivities and properties. Likewise, selenium (Se) and tellurium (Te) have been extensively studied during the last decades due to their possible therapeutical applications. Although there is limited research on the relationship between Se and Te and CDs, herein, we highlight different representative examples of the advances related to this topic as well as give our view on the future directions of this emerging area of research. This review encompasses three different aspects of this relationship: (1) modification of the structure of the different CDs; (2) formation of host-guest interaction complexes of naïve CDs with Se and Te derivatives in order to overcome specific limitations of the latter; and (3) the use of CDs as catalysts to achieve novel Se and Te compounds.
由于耐药性、不良副作用、临床效果不佳等问题的发生率不断上升,迫切需要开发更安全、更有效的治疗方法来治疗众多疾病。在过去几十年中,由于其能够提高生物活性和性质的能力,环糊精 (CD) 作为潜在的药物载体引起了广泛关注。同样,硒 (Se) 和碲 (Te) 在过去几十年中也得到了广泛研究,因为它们具有可能的治疗应用。尽管关于 Se 和 Te 与 CDs 之间关系的研究有限,但在这里,我们重点介绍了与这一主题相关的不同代表性示例,并就这一新兴研究领域的未来方向提出了我们的看法。这篇综述涵盖了这一关系的三个不同方面:(1)不同 CD 的结构修饰;(2)形成具有 Naive CDs 的主体 - 客体相互作用复合物,以克服后者的特定限制;(3)使用 CDs 作为催化剂来实现新型 Se 和 Te 化合物。